The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids 185receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45:3709–
3720
van der Stelt M, Hansen HH, Veldhuis WB, Bar PR, Nicolay K, Veldink GA, Vliegenthart
JF, Hansen HS (2003) Biosynthesis of endocannabinoids and their modes of action in
neurodegenerative diseases. Neurotox Res 5:183–200
Varga K, Wagner JA, Bridgen DT, Kunos G (1998) Platelet- and macrophage-derived endoge-
nous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12:1035–
1044
Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F,
Veldink GA, Vliegenthart JF, Bar PR, Nicolay K, Di Marzo V (2003) Neuroprotection by
the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in
the rat: role of vanilloid receptors and lipoxygenases. J Neurosci 23:4127–4133
Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap
junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590–594
Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G (1997) Activation of
peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390:518–521
WagnerJA,VargaK,JaraiZ,KunosG(1999)Mesentericvasodilationmediatedbyendothelial
anandamide receptors. Hypertension 33:429–434
WagnerJA,HuK,BauersachsJ,KarcherJ,WieslerM,GoparajuSK,KunosG,ErtlG
(2001) Endogenous cannabinoids mediate hypotension after experimental myocardial
infarction. J Am Coll Cardiol 38:2048–2054
Waleh NS, Cravatt BF, Apte-Deshpande A, Terao A, Kilduff TS (2002) Transcriptional regu-
lation of the mouse fatty acid amide hydrolase gene. Gene 291:203–210
Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC (1999) Pain modulation by
release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA 96:12198–
12203
Walter L, Stella N (2003) Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production
in astrocytes. Glia 44:85–90
Walter L, Stella N (2004) Cannabinoids and neuroinflammation. Br J Pharmacol 141:775–785
Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003)
Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci
23:1398–1405
Wang H, Matsumoto H, Guo Y, Paria BC, Roberts RL, Dey SK (2003) Differential G protein-
coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for
implantation. Proc Natl Acad Sci USA 100:14914–14919
Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B (2003) Anandamide and
arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature
424:434–438
Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other
centrally acting drugs. Eur J Pharmacol 471:185–193
Williams EJ, Walsh FS, Doherty P (2003) The FGF receptor uses the endocannabinoid
signaling system to couple to an axonal growth response. J Cell Biol 160:481–486
Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678–682
Yu M, Ives D, Ramesha CS (1997) Synthesis of prostaglandin E2 ethanolamide from anan-
damide by cyclooxygenase-2. J Biol Chem 272:21181–21186
ZygmuntPM,PeterssonJ,AnderssonDA,ChuangH,SorgardM,DiMarzoV,JuliusD,
Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator
action of anandamide. Nature 400:452–457
Zygmunt PM, Chuang H, Movahed P, Julius D, Hogestatt ED (2000) The anandamide trans-
port inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 396:39–42
ZygmuntPM,AnderssonDA,HogestattED(2002)Delta9-tetrahydrocannabinolandcannabi-
nol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-
independent mechanism. J Neurosci 22:4720–4727